@article{abbeMaleContraception2020,
  title = {Male {{Contraception}}},
  author = {Abbe, Carmen R. and Page, Stephanie T. and Thirumalai, Arthi},
  date = {2020-09-30},
  journaltitle = {The Yale Journal of Biology and Medicine},
  shortjournal = {Yale J Biol Med},
  volume = {93},
  number = {4},
  eprint = {33005125},
  eprinttype = {pmid},
  pages = {603--613},
  issn = {0044-0086},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513428/},
  urldate = {2023-03-15},
  abstract = {Unintended pregnancy is a global public health problem. Despite a variety of female contraceptive options, male contraceptive options are limited to the condom and vasectomy. Condoms have high failure rates and surgical vasectomy is not reliably reversible. There is a global need and desire for novel male contraceptive methods. Hormonal methods have progressed the furthest in clinical development and androgen plus progestin formulations hold promise as a marketable, reversible male contraceptive over the next decade. Investigators have tested androgen plus progestin approaches using oral, transdermal, subdermal, and injectable drug formulations and demonstrated the short-term safety and reversibility of hormonal male contraception. The most commonly reported side effects associated with hormonal male contraception include weight gain, acne, slight suppression of serum high-density cholesterol, mood changes, and changes in libido. Efficacy trials of hormonal male contraceptives have demonstrated contraceptive efficacy rates greater than that of condoms. Although there has been less progression in the development of nonhormonal male contraceptives, potentially reversible vaso-occlusive methods are currently in clinical trials in some countries. Various studies have confirmed both men and women’s desire for novel male contraceptives. Barriers to development include an absence of investment from pharmaceutical companies, concerns regarding side effects and spermatogenic rebound with hormonal methods, and lack of clear reversibility and proven effectiveness of nonhormonal methods. The ultimate availability of male contraceptives could have an important impact on decreasing global unintended pregnancy rates (currently 40\% of all pregnancies) and will be a step towards reproductive justice and greater equity in family planning.},
  pmcid = {PMC7513428},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\993XSE8J\\Abbe et al. - 2020 - Male Contraception.pdf}
}

@misc{associationfrancaisedurologieVasectomieContraceptive2012,
  title = {Vasectomie Contraceptive},
  author = {{Association Française d'Urologie}},
  date = {2012-05},
  url = {https://www.urofrance.org/sites/default/files/vasectomie_1.pdf},
  urldate = {2023-05-01},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\T8R8SBB5\\vasectomie_1.pdf}
}

@article{CesHommesQui2023,
  title = {Ces hommes qui ont choisi la vasectomie : « Notre sexualité est plus spontanée et plus sereine »},
  shorttitle = {Ces hommes qui ont choisi la vasectomie},
  date = {2023-04-10},
  journaltitle = {Le Monde.fr},
  url = {https://www.lemonde.fr/parentalite/article/2023/04/10/ces-hommes-qui-ont-choisi-la-vasectomie-notre-sexualite-est-plus-spontanee-et-plus-sereine_6168906_6145697.html},
  urldate = {2023-04-11},
  abstract = {Cette méthode de stérilisation masculine reste marginale en France, bien qu’en hausse. Répartition de la charge contraceptive, refus de procréer dans un monde troublé… Les motivations sont diverses, et les regrets peu nombreux.},
  entrysubtype = {newspaper},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\83FESL9D\\ces-hommes-qui-ont-choisi-la-vasectomie-notre-sexualite-est-plus-spontanee-et-plus-sereine_6168.html}
}

@inreference{CoitInterrompu2022,
  title = {Coït interrompu},
  booktitle = {Wikipédia},
  date = {2022-06-21T07:38:46Z},
  url = {https://fr.wikipedia.org/w/index.php?title=Co%C3%AFt_interrompu&oldid=194713871},
  urldate = {2023-05-01},
  abstract = {Le coït interrompu (coitus interruptus en latin) ou méthode du retrait est une pratique sexuelle et un moyen de contraception qui consiste à interrompre le rapport sexuel vaginal juste avant l'éjaculation. L'homme retire à ce moment son pénis du vagin et l'éjaculation a alors lieu en dehors de celui-ci, évitant ainsi la fécondation. La méthode du retrait fait partie des méthodes naturelles de régulation des naissances. Bien qu'ancienne, la méthode du retrait a été largement popularisée dans les films pornographiques à partir des années 1980. En effet, à l'écran une éjaculation hors du vagin rend davantage visible cette éjaculation tout en se passant du préservatif (Débat sur l'utilisation du préservatif dans l'industrie du film pornographique). Cette méthode de contraception a néanmoins une efficacité beaucoup plus faible que les méthodes plus classiques. Elle ne protège en outre pas des infections sexuellement transmissibles. La méthode du retrait ne doit pas être confondue avec le contrôle de l'orgasme (ou edging) qui est une technique d'intensification du plaisir sexuel ni avec le déni d'orgasme qui relève des pratiques BDSM.},
  langid = {french},
  annotation = {Page Version ID: 194713871},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\P4RNRTKT\\Coït_interrompu.html}
}

@online{CoitInterrompuWikipedia,
  title = {Coït Interrompu — {{Wikipédia}}},
  url = {https://fr.wikipedia.org/wiki/Co%C3%AFt_interrompu?oldformat=true},
  urldate = {2023-05-01},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KIERFDXZ\\Coït_interrompu.html}
}

@online{ContraceptionChezHomme2019,
  title = {Contraception chez l’homme},
  date = {2019-09},
  url = {https://www.has-sante.fr/jcms/c_1757909/fr/contraception-chez-l-homme},
  urldate = {2023-02-22},
  abstract = {Cette fiche mémo, fondée sur les recommandations les plus récentes, fait partie d’un ensemble de fiches mémo concernant la contraception et complète plusieurs documents sur ce thème produits par la HAS. Elle est un outil pour le professionnel de santé afin de mieux aider les femmes/les hommes à trouver la méthode de contraception qui leur convient le mieux à une période donnée de leur vie.},
  langid = {french},
  organization = {{Haute Autorité de Santé}},
  keywords = {HAS,masculin,officiel},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\PQ56WL3J\\contraception-chez-l-homme.html}
}

@online{ContraceptionMasculine,
  title = {La Contraception Masculine},
  url = {https://questionsexualite.fr/choisir-sa-contraception/ma-contraception-et-moi/contraception-masculine-comment-ca-marche},
  urldate = {2023-03-02},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\9ERTACE7\\contraception-masculine-comment-ca-marche.html}
}

@article{ContraceptionMasculineArretez2022,
  title = {contraception masculine arrêtez de vous dorer la pilule !},
  date = {2022-08-23},
  journaltitle = {Libération},
  pages = {1},
  url = {https://nouveau.europresse.com/Link/BUCOMPIEGNET_2/news%C2%B720220823%C2%B7LI%C2%B7181143014},
  abstract = {Appel Libération» demande aux pouvoirs publics et aux laboratoires de développer de vraies solutions pour que la  contraception soit autant une affaire d'hommes que de femmes. pages 2-5  ...},
  langid = {FRA},
  annotation = {Context Object: ctx\_ver=Z39.88-2004\&rft\_val\_fmt=info\%3Aofi\%2Ffmt\%3Akev\%3Amtx\%3Ajournal\&rft.genre=article\&rft.atitle=contraception\%20masculine\%20arr\%c3\%aatez\%20de\%20vous\%20dorer\%20la\%20pilule\%20!\&rft.jtitle=Lib\%c3\%a9ration\&rft.title=Lib\%c3\%a9ration\&rft.description=Appel\%20Lib\%c3\%a9ration\%c2\%bb\%20demande\%20aux\%20pouvoirs\%20publics\%20et\%20aux\%20laboratoires\%20de\%20d\%c3\%a9velopper\%20de\%20vraies\%20solutions\%20pour\%20que\%20la\%20\%20contraception\%20soit\%20autant\%20une\%20affaire\%20d\%27hommes\%20que\%20de\%20femmes.\%20pages\%202-5\%20\%20...\&rft.date=2022-08-23\&rft.language=FRA\&rft.spage=1\&rft.epage=1\&rft\_id=https://nouveau.europresse.com/Link/BUCOMPIEGNET\_2/news\%c2\%b720220823\%c2\%b7LI\%c2\%b7181143014},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KQFWN8YR\\6.html}
}

@article{ContraceptionSeDecline1982,
  title = {La contraception se décline au masculin},
  date = {1982-02-27},
  journaltitle = {Le Monde.fr},
  url = {https://www.lemonde.fr/archives/article/1982/02/27/la-contraception-se-decline-au-masculin_2885260_1819218.html},
  urldate = {2023-03-06},
  abstract = {Un groupe de dix hommes a commencé, en mars 1981, à Lyon, une expérience contraceptive hormonale. Peu avant la fin de leur},
  entrysubtype = {newspaper},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\IV3YEYMP\\la-contraception-se-decline-au-masculin_2885260_1819218.html}
}

@online{ContraceptionsMasculinesCa,
  title = {Les contraceptions "masculines" ça existe ? Et oui !!},
  shorttitle = {Les contraceptions "masculines" ça existe ?},
  url = {https://www.planning-familial.org/fr/le-planning-familial-de-gironde-33/contraception/les-contraceptions-masculines-ca-existe-et-oui},
  urldate = {2023-03-02},
  langid = {french},
  organization = {{Le planning familial}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KQMX7C2F\\les-contraceptions-masculines-ca-existe-et-oui.html}
}

@inreference{Cryptorchidie2023,
  title = {Cryptorchidie},
  booktitle = {Wikipédia},
  date = {2023-01-31T14:49:53Z},
  url = {https://fr.wikipedia.org/w/index.php?title=Cryptorchidie&oldid=200954426},
  urldate = {2023-03-07},
  abstract = {La cryptorchidie, appelée aussi trouble de la migration du testicule, ou plus communément testicule mal descendu, est l'absence d'un ou des deux testicules dans le scrotum (position normale introscrotale chez l'homme et chez les animaux à testicules externes). Elle inclut l’ectopie testiculaire, qui est l'insertion du testicule dans un autre endroit, hors des bourses et de son trajet normal, en raison d'un arrêt de la migration du testicule lors de son trajet de descente ; entre la région lombaire où il se forme et son emplacement naturel dans le scrotum.  Le testicule est dit ectopique s'il se trouve au niveau crural ou plus haut si sa descente a été bloquée. Ces deux anomalies, notamment si associées à un hypospadias ou micropénis peuvent être un des éléments du syndrome de dysgénésie testiculaire. Dans certains cas, il peut y avoir doute sur le sexe de l'individu (« ambiguïté sexuelle » ou intersexe)},
  langid = {french},
  annotation = {Page Version ID: 200954426},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\Z2E2KGA3\\Cryptorchidie.html}
}

@article{decraenPlacebosPlaceboEffects1999,
  title = {Placebos and Placebo Effects in Medicine: Historical Overview},
  shorttitle = {Placebos and Placebo Effects in Medicine},
  author = {De Craen, Anton J M and Kaptchuk, Ted J and Tijssen, Jan G P and Kleijnen, J},
  date = {1999-10},
  journaltitle = {Journal of the Royal Society of Medicine},
  shortjournal = {J R Soc Med},
  volume = {92},
  number = {10},
  pages = {511--515},
  issn = {0141-0768, 1758-1095},
  doi = {10.1177/014107689909201005},
  url = {http://journals.sagepub.com/doi/10.1177/014107689909201005},
  urldate = {2023-03-10},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\DEHICDUM\\De Craen et al. - 1999 - Placebos and placebo effects in medicine historic.pdf}
}

@video{denisvanwaerebekeJamesOuRoman2018,
  title = {James Ou Le Roman d'un Médicament},
  date = {2018-11-15},
  url = {https://www.youtube.com/watch?v=DtuHTgCN68Y},
  urldate = {2023-03-10},
  abstract = {Cette molécule-là ira loin ! Sélectionnée parmi des milliers de molécules, James (c'est son nom) est passée à la moulinette des essais chimiques, puis thérapeutiques... Un protocole hyper rigoureux raconté avec clarté et humour.},
  editora = {{Denis van Waerebeke} and {Jimmy Audoin} and {Ruelgo} and {Vicent Bordelais} and {Claire lise} and {Carine Leblanc} and {Martine Zwerin}},
  editoratype = {scriptwriter}
}

@online{DeveloppementMedicamentInserm,
  title = {Développement du médicament - Inserm, La science pour la santé},
  url = {https://www.inserm.fr/dossier/medicament-developpement/},
  urldate = {2023-03-10},
  abstract = {Phase préclinique, clinique, obtention de l’autorisation de mise sur le marché… Près de 15 ans sont nécessaires pour qu’une molécule d’intérêt thérapeutique devienne un « vrai médicament » (hors dispositifs médicaux). Un parcours long et très réglementé qui aura raison de nombreuses molécules candidates se révélant finalement mal tolérées ou…},
  langid = {french},
  organization = {{Inserm}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\JX7NXESD\\medicament-developpement.html}
}

@online{DocumentSansTitre,
  title = {Document sans titre},
  url = {https://docs.google.com/document/u/0/d/1PS4dyNbeTdl8silYYTTwjHrqAgZ6Kz1Oxr2Uqg8qU-Y/edit?usp=embed_facebook},
  urldate = {2023-03-15},
  langid = {french},
  organization = {{Google Docs}}
}

@online{EfficaciteMoyensContraceptifs,
  title = {Efficacité des moyens contraceptifs},
  url = {https://www.ameli.fr/assure/sante/themes/contraception/efficacite-moyens-contraceptifs},
  urldate = {2023-05-01},
  abstract = {Aucun moyen contraceptif n’est efficace à 100 \%. On distingue l’efficacité théorique (indice de Pearl) et l’efficacité pratique.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\LLDNEMVD\\efficacite-moyens-contraceptifs.html}
}

@misc{flegmusPreservatifMasculinEnroule2023,
  title = {Préservatif masculin enroulé},
  author = {{Flegmus}},
  date = {2023-04-20T19:08:19Z},
  url = {https://fr.wikipedia.org/w/index.php?title=Pr%C3%A9servatif&oldid=203527478},
  urldate = {2023-05-01},
  abstract = {Le préservatif ou condom (ou capote, plus familier, en Suisse, au Québec et en France) est un étui mince et souple, imperméable au sang, au sperme ainsi qu'aux sécrétions vaginales et péniennes, fabriqué en latex ou en polyuréthane. Il en existe deux types : le préservatif externe (masculin) et le préservatif interne (féminin). Le premier est aussi nommé plus familièrement « capote » en français européen. Le préservatif s'avère être très efficace pour empêcher la transmission des infections sexuellement transmissibles (IST) par les sécrétions vaginales, péniennes et le sperme mais n'offre pas de protection face aux IST présentes sur les surfaces cutanées de la zone génitale. Ainsi le préservatif, correctement utilisé lors d'une relation sexuelle avec pénétration, est le seul contraceptif qui protège de la transmission du VIH et de l'hépatite B. Il ne constitue en revanche pas une protection efficace contre d'autres IST occasionnant un nombre important de décès, comme la syphilis (30\% de protection seulement) ou encore le papillomavirus humain , responsable de plusieurs types de cancers dont le cancer du col de l'utérus et contre lequel seule la vaccination s'avère efficace. Enfin, il ne permet pas non plus de se protéger contre l'herpès génital responsable de conséquences psychologiques et sociales importantes pour la personne atteinte et dont la transmission au fœtus durant l'accouchement, appelée herpès néonatal, occasionne une importante mortalité et des séquelles lourdes.},
  langid = {french},
  annotation = {Page Version ID: 203527478},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\U2Z6AFKT\\Préservatif.html}
}

@article{freeMaleContraceptionPrescription,
  title = {Male {{Contraception Without Prescription}}},
  author = {Free, Michael J and Alexander, Nancy J},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\35CST9NT\\Free et Alexander - Male Contraception Without Prescription.pdf}
}

@article{GratuiteContraceptionPour2021,
  title = {La gratuité de la contraception pour les femmes de 18 à 25 ans, une mesure adoptée à l’Assemblée nationale},
  date = {2021-10-23},
  journaltitle = {Le Monde.fr},
  url = {https://www.lemonde.fr/sante/article/2021/10/23/contraception-l-assemblee-nationale-adopte-a-l-unanimite-la-gratuite-pour-les-femmes-de-18-a-25-ans_6099612_1651302.html},
  urldate = {2023-04-05},
  abstract = {Trois millions de jeunes femmes sont potentiellement concernées par ce dispositif qui entrera en vigueur le 1er~janvier~2022.},
  entrysubtype = {newspaper},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\REZUBD22\\contraception-l-assemblee-nationale-adopte-a-l-unanimite-la-gratuite-pour-les-femmes-de-18-a-25.html}
}

@book{guillaumedaudinContraceptesEnqueteDernier2022,
  title = {Les contraceptés enquête sur le dernier tabou},
  author = {{Guillaume Daudin} and {Stéphane Jourdain}},
  date = {2022-03},
  publisher = {{Steinkis}},
  editora = {{Caroline Lee}},
  editoratype = {collaborator},
  isbn = {978-2-36846-430-4},
  langid = {french},
  pagetotal = {143}
}

@article{heinemannAttitudesMaleFertility2005,
  title = {Attitudes toward Male Fertility Control: Results of a Multinational Survey on Four Continents},
  shorttitle = {Attitudes toward Male Fertility Control},
  author = {Heinemann, Klaas and Saad, Farid and Wiesemes, Martin and White, Steven and Heinemann, Lothar},
  date = {2005-02-01},
  journaltitle = {Human Reproduction},
  volume = {20},
  number = {2},
  pages = {549--556},
  issn = {1460-2350, 0268-1161},
  doi = {10.1093/humrep/deh574},
  url = {http://academic.oup.com/humrep/article/20/2/549/603220/Attitudes-toward-male-fertility-control-results-of},
  urldate = {2023-02-22},
  abstract = {BACKGROUND: Following extensive research activity to develop an effective agent to control male fertility, such a product may be available for use within ,5 years. However, little is known concerning contraceptive knowledge, desires and attitudes of men in different countries, and their acceptance of male fertility control (MFC). METHODS: A survey of {$>$} 9000 males aged 18 – 50 years was performed in nine countries on four continents in 2002. The objective was to compare, on a cross-cultural basis, the knowledge, attitudes and acceptability of MFC among men and assess their willingness to use such a method. RESULTS: Between 50 and 83\% of the male respondents currently use contraceptive methods, and 55 – 81.5\% reported that both partners participate in selecting the method of contraception employed. Overall acceptance of hormonal MFC was high ({$>$}55\%), with 28.5– 71.4\% of survey participants of various nationalities expressing the willingness to use such a method. CONCLUSION: While MFC appears to be well accepted overall, the willingness to use this type of contraception varies widely between differing population groups. The specific characteristics and profile of any MFC product will have to be carefully evaluated to accurately assess its acceptance, both by men and their female partners.},
  langid = {english},
  keywords = {article,avis,masculin},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\F23P9W8X\\Heinemann et al. - 2005 - Attitudes toward male fertility control results o.pdf}
}

@online{huetMeetPioneersTurning2023,
  title = {Meet the Pioneers Turning Birth Control into a Male Affair},
  author = {Huet, Natalie},
  date = {2023-04-03},
  url = {https://www.euronews.com/next/2023/04/03/future-birth-control-couples-testing-experimental-male-contraceptives-nestorone-gel},
  urldate = {2023-04-05},
  abstract = {From homemade jockstraps to a shoulder gel that slashes sperm counts, these couples are testing new male contraceptives to better share the burden of birth control.},
  langid = {english},
  organization = {{euronews}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\9G3MENF8\\future-birth-control-couples-testing-experimental-male-contraceptives-nestorone-gel.html}
}

@online{lachaudEgaliteFautPromouvoir2021,
  title = {Égalité : il faut promouvoir la contraception masculine},
  shorttitle = {Égalité},
  author = {Lachaud, Bastien},
  date = {2021-09-21T18:06:11+00:00},
  url = {https://bastienlachaud.fr/2021/09/21/egalite-promouvoir-contraception-masculine/},
  urldate = {2023-04-05},
  abstract = {La contraception est une affaire de partenaires, sa responsabilité n'incombe pas aux femmes. Il faut promouvoir la contraception masculine.},
  langid = {french},
  organization = {{Bastien Lachaud}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KLARR8TU\\egalite-promouvoir-contraception-masculine.html}
}

@article{lohiyaRISUGIntravasalInjectable2014,
  title = {{{RISUG}}: {{An}} Intravasal Injectable Male Contraceptive},
  author = {Lohiya, N K and Alam, I and Hussain, M and Khan, S R and Ansari, A S},
  date = {2014},
  journaltitle = {INDIAN J MED RES},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\5GCT53E8\\IJMR-140-63.pdf;C\:\\Users\\esteb\\Zotero\\storage\\9D7ZDDQW\\274948_spf00001571.pdf}
}

@article{longUpdateNovelHormonal2021,
  title = {Update on {{Novel Hormonal}} and {{Nonhormonal Male Contraceptive Development}}},
  author = {Long, Jill E and Lee, Min S and Blithe, Diana L},
  date = {2021-05-13},
  journaltitle = {The Journal of Clinical Endocrinology \& Metabolism},
  volume = {106},
  number = {6},
  pages = {e2381-e2392},
  issn = {0021-972X, 1945-7197},
  doi = {10.1210/clinem/dgab034},
  url = {https://academic.oup.com/jcem/article/106/6/e2381/6108319},
  urldate = {2023-02-22},
  abstract = {Background:\hspace{0.6em}The advent of new methods of male contraception would increase contraceptive options for men and women and advance male contraceptive agency. Pharmaceutical R\&D for male contraception has been dormant since the 1990s. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has supported a contraceptive development program since 1969 and supports most ongoing hormonal male contraceptive development. Nonhormonal methods are in earlier stages of development.},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\98B4LLZG\\Long et al. - 2021 - Update on Novel Hormonal and Nonhormonal Male Cont.pdf}
}

@online{MaladiesInfectionsSexuellement,
  title = {Maladies et infections sexuellement transmissibles},
  url = {https://www.ameli.fr/assure/sante/themes/mst-ist/maladies-infections-sexuellement-transmissibles},
  urldate = {2023-05-01},
  abstract = {Les infections sexuellement transmissibles ou IST sont des infections dues à des bactéries, virus et parasites, et transmises par voie sexuelle.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\TCG7WJMJ\\maladies-infections-sexuellement-transmissibles.html}
}

@article{manettiUpdateMaleHormonal2010,
  title = {Update on {{Male Hormonal Contraception}}: {{Is}} the {{Vasectomy}} in {{Jeopardy}}?},
  shorttitle = {Update on {{Male Hormonal Contraception}}},
  author = {Manetti, G J and Honig, S C},
  date = {2010-05},
  journaltitle = {International Journal of Impotence Research},
  shortjournal = {Int J Impot Res},
  volume = {22},
  number = {3},
  pages = {159--170},
  issn = {0955-9930, 1476-5489},
  doi = {10.1038/ijir.2010.2},
  url = {https://www.nature.com/articles/ijir20102},
  urldate = {2023-02-22},
  langid = {english},
  keywords = {masculine}
}

@article{manettiUpdateMaleHormonal2010a,
  title = {Update on {{Male Hormonal Contraception}}: {{Is}} the {{Vasectomy}} in {{Jeopardy}}?},
  shorttitle = {Update on {{Male Hormonal Contraception}}},
  author = {Manetti, G J and Honig, S C},
  date = {2010-05},
  journaltitle = {International Journal of Impotence Research},
  shortjournal = {Int J Impot Res},
  volume = {22},
  number = {3},
  pages = {159--170},
  issn = {0955-9930, 1476-5489},
  doi = {10.1038/ijir.2010.2},
  url = {https://www.nature.com/articles/ijir20102},
  urldate = {2023-02-22},
  langid = {english},
  keywords = {article,masculine}
}

@article{manettiUpdateMaleHormonal2010b,
  title = {Update on {{Male Hormonal Contraception}}: {{Is}} the {{Vasectomy}} in {{Jeopardy}}?},
  shorttitle = {Update on {{Male Hormonal Contraception}}},
  author = {Manetti, G J and Honig, S C},
  date = {2010-05},
  journaltitle = {International Journal of Impotence Research},
  shortjournal = {Int J Impot Res},
  volume = {22},
  number = {3},
  pages = {159--170},
  issn = {0955-9930, 1476-5489},
  doi = {10.1038/ijir.2010.2},
  url = {https://www.nature.com/articles/ijir20102},
  urldate = {2023-02-22},
  langid = {english},
  keywords = {article,masculin},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\K4ZDUSEL\\Manetti et Honig - 2010 - Update on Male Hormonal Contraception Is the Vase.pdf}
}

@article{marlenethomasContraceptionMasculineArretez2022,
  title = {Contraception masculine arrêtez de vous dorer la pilule !},
  author = {{Marlène Thomas} and {Dov Alfon} and {Viriginie Ballet} and {Camille Gévaudant}},
  date = {2022-08-23},
  journaltitle = {Libération},
  pages = {2--5},
  entrysubtype = {newspaper},
  langid = {french}
}

@article{mieussetHyperthermiaHumanSpermatogenesis1987,
  title = {Hyperthermia and Human Spermatogenesis: Enhancement of the Inhibitory Effect Obtained by ‘Artificial Cryptorchidism’},
  shorttitle = {Hyperthermia and Human Spermatogenesis},
  author = {Mieusset, R. and Bujan, L. and Mansat, Arlette and Pontonnier, F. and Grandjean, Hélène},
  date = {1987-08},
  journaltitle = {International Journal of Andrology},
  shortjournal = {Int J Androl},
  volume = {10},
  number = {4},
  pages = {571--580},
  issn = {0105-6263, 1365-2605},
  doi = {10.1111/j.1365-2605.1987.tb00356.x},
  url = {https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2605.1987.tb00356.x},
  urldate = {2023-03-07},
  abstract = {Decreased sperm count and motility were observed in men after induction of local testicular hyperthermia by raising the testicles into the inguinal canal during the day in adult volunteers. A similar technique in which the testicles were better maintained in the inguinal canal resulted in more marked suppression of spermatogenesis. As assessed by the total motile sperm count, the mean inhibitory effect of hyperthermia was at least 97\% after 2 months using this technique. This effect of ‘artificial cryptorchidism’ may be of practical interest in the manipulation of male fertility.},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KY3KV885\\Mieusset et al. - 1987 - Hyperthermia and human spermatogenesis enhancemen.pdf}
}

@article{mieussetInhibitingEffectArtificial1985,
  title = {Inhibiting Effect of Artificial Cryptorchidism on Spermatogenesis},
  author = {Mieusset, Roger and Grandjean, Hélène and Mansat, Arlette and Pontonnier, Francis},
  date = {1985-04},
  journaltitle = {Fertility and Sterility},
  shortjournal = {Fertility and Sterility},
  volume = {43},
  number = {4},
  pages = {589--594},
  issn = {00150282},
  doi = {10.1016/S0015-0282(16)48502-X},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S001502821648502X},
  urldate = {2023-03-07},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\YGCQIIBV\\Mieusset et al. - 1985 - Inhibiting effect of artificial cryptorchidism on .pdf}
}

@article{mieussetPotentialMildTesticular1994,
  title = {The Potential of Mild Testicular Heating as a Safe, Effective and Reversible Contraceptive Method for Men},
  author = {Mieusset, Roger and B'Ujan, Louis},
  date = {1994-08},
  journaltitle = {International Journal of Andrology},
  shortjournal = {Int J Androl},
  volume = {17},
  number = {4},
  pages = {186--191},
  issn = {0105-6263, 1365-2605},
  doi = {10.1111/j.1365-2605.1994.tb01241.x},
  url = {https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2605.1994.tb01241.x},
  urldate = {2023-03-07},
  abstract = {A preliminary assessment of the contraceptive efficacy of a daily mild increase (1-2OC) in testicular temperature during waking hours is reported in nine couples using two techniques of non-surgical fixation of the testes close to the inguinal canal. With technique 1, immobilization was achieved by passing the penis and the empty scrotum through a hole made in close-fitting underwear; there was one pregnancy, h m a man who stopped the heating after 7 weeks, for 42 cycles of exposure in three couples. With technique 2, immobilization was achieved by adding a ring of soft material surrounding the hole in the underwear; there was no pregnancy for 117 cycles of exposure in six couples. Reversibility and safety were assessed. These preliminary results suggest that a daily mild increase in testicular temperature could be a potential contraceptive method for men.},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\A2N8LD5U\\Mieusset et B'Ujan - 1994 - The potential of mild testicular heating as a safe.pdf}
}

@article{mieussetPotentialMildTesticular1994a,
  title = {The Potential of Mild Testicular Heating as a Safe, Effective and Reversible Contraceptive Method for Men},
  author = {Mieusset, Roger and B'Ujan, Louis},
  date = {1994-08},
  journaltitle = {International Journal of Andrology},
  shortjournal = {Int J Androl},
  volume = {17},
  number = {4},
  pages = {186--191},
  issn = {0105-6263, 1365-2605},
  doi = {10.1111/j.1365-2605.1994.tb01241.x},
  url = {https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2605.1994.tb01241.x},
  urldate = {2023-03-07},
  abstract = {A preliminary assessment of the contraceptive efficacy of a daily mild increase (1-2OC) in testicular temperature during waking hours is reported in nine couples using two techniques of non-surgical fixation of the testes close to the inguinal canal. With technique 1, immobilization was achieved by passing the penis and the empty scrotum through a hole made in close-fitting underwear; there was one pregnancy, h m a man who stopped the heating after 7 weeks, for 42 cycles of exposure in three couples. With technique 2, immobilization was achieved by adding a ring of soft material surrounding the hole in the underwear; there was no pregnancy for 117 cycles of exposure in six couples. Reversibility and safety were assessed. These preliminary results suggest that a daily mild increase in testicular temperature could be a potential contraceptive method for men.},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\T8SNNHQY\\Mieusset et B'Ujan - 1994 - The potential of mild testicular heating as a safe.pdf}
}

@online{PreservatifWikipedia,
  title = {Préservatif — {{Wikipédia}}},
  url = {https://fr.wikipedia.org/wiki/Pr%C3%A9servatif?oldformat=true},
  urldate = {2023-05-01},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\PJSPBZLK\\Préservatif.html}
}

@online{PreventionIST,
  title = {Prévention des IST},
  url = {https://www.ameli.fr/assure/sante/themes/mst-ist/prevention},
  urldate = {2023-05-01},
  abstract = {La prévention des infections sexuellement transmissibles passe principalement par l’utilisation du préservatif et pour certaines par la vaccination.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\EQVRTG5A\\prevention.html}
}

@online{Question41326Assemblee,
  title = {Question N°41326 - {{Assemblée}} Nationale},
  url = {https://questions.assemblee-nationale.fr/q15/15-41326QE.htm},
  urldate = {2023-04-05}
}

@online{Question41326Assembleea,
  title = {Question N°41326 - {{Assemblée}} Nationale},
  url = {https://questions.assemblee-nationale.fr/q15/15-41326QE.htm},
  urldate = {2023-04-05}
}

@inreference{Risug2021,
  title = {Risug},
  booktitle = {Wikipédia},
  date = {2021-02-11T07:52:00Z},
  url = {https://fr.wikipedia.org/w/index.php?title=Risug&oldid=179797257},
  urldate = {2023-02-22},
  abstract = {Le  RISUG  (Reversible Inhibition of Sperm Under Guidance), anciennement dénommé SMA,  est le nom de développement d'un contraceptif masculin développé à l'Institut indien de technologie de Kharagpur en Inde par le Dr Sujoy K. Guha. Il est actuellement en phase III des essais cliniques[réf. nécessaire] (visant à établir l'efficacité et la tolérance du contraceptif masculin). Ce dernier a été breveté en Inde, en Chine, au Bangladesh, aux États-Unis et au Canada.},
  langid = {french},
  keywords = {masculin},
  annotation = {Page Version ID: 179797257},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\R5PKC8MU\\Risug.html}
}

@misc{santepublicfranceChoisirSaContraception2019,
  title = {Choisir sa contraception},
  author = {{Sante public france}},
  date = {2019-10},
  url = {https://www.santepubliquefrance.fr/content/download/461303/3575583?version=1},
  editora = {{Service du droit des femmes et de l’égalité} and {Association française pour la contraception} and {Mouvement français pour le planning familial} and {Centre régional d’information et de prévention du sida Île-de-France}},
  editoratype = {collaborator},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\A5YBTMQ9\\274948_spf00001571.pdf}
}

@article{SexualiteHommesAbsents2023,
  title = {Sexualité : les hommes absents de la conversation},
  shorttitle = {Sexualité},
  date = {2023-04-02},
  journaltitle = {Le Monde.fr},
  url = {https://www.lemonde.fr/m-perso/article/2023/04/02/sexualite-les-hommes-absents-de-la-conversation_6167920_4497916.html},
  urldate = {2023-04-05},
  abstract = {CHRONIQUE. Rares sont les experts à s’exprimer sur les questions sexuelles ou de genre, constate Maïa Mazaurette, la chroniqueuse de «~La Matinale~», qui déplore cette sous-représentation~: la société dans son ensemble bénéficierait de paroles masculines libres et informées.},
  entrysubtype = {newspaper},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\Y9XDVGF2\\sexualite-les-hommes-absents-de-la-conversation_6167920_4497916.html}
}

@online{SterilisationViseeContraceptive,
  title = {Stérilisation à visée contraceptive},
  url = {https://www.ameli.fr/assure/sante/themes/contraception/sterilisation-contraceptive-homme-femme},
  urldate = {2023-05-01},
  abstract = {La stérilisation à visée contraceptive ne peut être pratiquée que chez une personne majeure (homme ou femme). C'est une méthode permanente et irréversible.},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\9L3CVE25\\sterilisation-contraceptive-homme-femme.html}
}

@online{TousMoyensContraception2023,
  title = {Tous Les Moyens de Contraception Dans Un Tableau Comparatif.},
  date = {2023-02-22},
  url = {https://questionsexualite.fr/choisir-sa-contraception/ma-contraception-et-moi/tableau-comparatif-pour-vous-guider-dans-votre-choix-de-contraception},
  urldate = {2023-02-22},
  keywords = {comparatif,feminin,masculin,officiel},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\BI8R8L96\\tableau-comparatif-pour-vous-guider-dans-votre-choix-de-contraception.html}
}

@online{VasectomieEstelleReversible,
  title = {La vasectomie est-elle réversible, comme le dit la série «The Office» ?},
  url = {https://www.liberation.fr/checknews/2019/07/05/la-vasectomie-est-elle-reversible-comme-le-dit-la-serie-the-office_1737961/},
  urldate = {2023-05-01},
  abstract = {La vasectomie est une méthode considérée comme définitive, car la réussite de l'opération inverse n'est pas garantie.},
  langid = {french},
  organization = {{Libération}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\NE8CR5FD\\la-vasectomie-est-elle-reversible-comme-le-dit-la-serie-the-office_1737961.html}
}

@online{VasectomieToutSavoir2017,
  title = {La vasectomie : tout savoir sur la stérilisation masculine},
  shorttitle = {La vasectomie},
  date = {2017-09-24},
  url = {https://www.passeportsante.net/fr/Maux/examens-medicaux-operations/Fiche.aspx?doc=vasectomie},
  urldate = {2023-05-01},
  abstract = {La vasectomie est une technique de stérilisation masculine considérée comme définitive. Elle consiste empêcher les spermatozoïdes d’être incorporés à l’éjaculat.},
  langid = {french},
  organization = {{https://www.passeportsante.net/}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\E5XVXINI\\Fiche.html}
}

@article{VersPiluleContraceptive2012,
  title = {Vers une pilule contraceptive masculine},
  date = {2012-08-16},
  journaltitle = {Le Monde.fr},
  url = {https://www.lemonde.fr/sciences/article/2012/08/16/vers-une-pilule-contraceptive-masculine_1746855_1650684.html},
  urldate = {2023-03-06},
  abstract = {Un nouveau front s'est ouvert dans la quête d'un contraceptif masculin : grâce à une petite molécule, la fabrication de spermatozoïdes a pu être bloquée de façon spécifique et réversible chez des souris.},
  entrysubtype = {newspaper},
  langid = {french},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\DJEBP4LN\\vers-une-pilule-contraceptive-masculine_1746855_1650684.html}
}

@article{waitesDevelopmentMethodsMale2003,
  title = {Development of Methods of Male Contraception: Impact of the {{World Health Organization Task Force}}},
  shorttitle = {Development of Methods of Male Contraception},
  author = {Waites, Geoffrey M.H.},
  date = {2003-07},
  journaltitle = {Fertility and Sterility},
  shortjournal = {Fertility and Sterility},
  volume = {80},
  number = {1},
  pages = {1--15},
  issn = {00150282},
  doi = {10.1016/S0015-0282(03)00577-6},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S0015028203005776},
  urldate = {2023-02-28},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\KCE2L8YR\\Waites - 2003 - Development of methods of male contraception impa.pdf}
}

@article{wangBETBromodomainInhibitor2022,
  title = {{{BET}} Bromodomain Inhibitor {{JQ1}} Regulates Spermatid Development by Changing Chromatin Conformation in Mouse Spermatogenesis},
  author = {Wang, Xiaorong and Sang, Mengmeng and Gong, Shengnan and Chen, Zhichuan and Zhao, Xi and Wang, Guishuan and Li, Zhiran and Huang, Yingying and Chen, Shitao and Xie, Gangcai and Duan, Enkui and Sun, Fei},
  date = {2022-07},
  journaltitle = {Genes \& Diseases},
  shortjournal = {Genes \& Diseases},
  volume = {9},
  number = {4},
  pages = {1062--1073},
  issn = {23523042},
  doi = {10.1016/j.gendis.2020.12.012},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S2352304221000076},
  urldate = {2023-03-06},
  langid = {english},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\GN4M6TIJ\\Wang et al. - 2022 - BET bromodomain inhibitor JQ1 regulates spermatid .pdf}
}

@online{WikiwandPreservatif1920,
  title = {Wikiwand - {{Préservatif}}},
  date = {1920-07-31},
  url = {https://wikiwand.com/fr/Préservatif},
  urldate = {2023-05-01},
  abstract = {Le préservatif ou condom est un étui mince et souple, imperméable au sang, au sperme ainsi qu'aux sécrétions vaginales et péniennes, fabriqué en latex ou en polyuréthane. Il en existe deux types : le préservatif externe et le préservatif interne . Le premier est aussi nommé plus familièrement « capote » en français européen. Le préservatif s'avère être très efficace pour empêcher la transmission des infections sexuellement transmissibles par les sécrétions vaginales, péniennes et le sperme mais n'offre pas de protection face aux IST présentes sur les surfaces cutanées de la zone génitale. Ainsi le préservatif, correctement utilisé lors d'une relation sexuelle avec pénétration, est le seul contraceptif qui protège de la transmission du VIH et de l'hépatite B. Il ne constitue en revanche pas une protection efficace contre d'autres IST occasionnant un nombre important de décès, comme la syphilis .},
  organization = {{Wikiwand}},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\AI3AI3PQ\\Préservatif.html}
}

@online{ZoteroYourPersonal,
  title = {Zotero | {{Your}} Personal Research Assistant},
  url = {https://www.zotero.org/start},
  urldate = {2023-02-22},
  file = {C\:\\Users\\esteb\\Zotero\\storage\\LSCHTE7Z\\start.html}
}
